Cidara Therapeutics announced the resignation of board member Laura Tadvalkar and the separation of Chief Medical Officer Taylor Sandison, who will receive nine months of salary and health coverage; Josh Resnick was appointed to the board with a $40,000 annual retainer and stock options.